Thermoacoustic Method for Estimating Liver Fat Fraction
Endra Lifesciences · NCT07321925
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 49
- US sites recruiting
- 1
- Study start
- August 15, 2025
- Record last updated
- January 7, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to use our Thermoacoustic Enhanced Ultrasound device to measure the fat levels in your liver and compare it to the the gold standard MRI PDFF measurements. Participants will have a scan with our device, then they will go have an abdominal MRI completed. The goal is to create a more accessible device to measure liver fat as it is an indicator for overall health and metabolic diseases.
Being studied: Thermoacoustic Enhanced Ultrasound
Conditions: MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis); Fatty Liver Disease, Nonalcoholic
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Study participants are 18 or older.
- Able to understand, read, and provide written informed consent in English.
- Able to tolerate both ultrasound and MRI examinations.
- Able to lie flat, or on their side, for 20 minutes and pause breathing for up to 10 seconds.
Exclusion Criteria
- Metal or electronic implants, including, but not limited to: pacemakers, metal clips, drug delivery pumps, hip implants, and neural stimulation devices, contraindicates for MRI.
- Known pregnancy the day of consent or becoming pregnant during study participation based on start date of last menstrual period).
- Liver diseases other than MASLD/MASH/fibrosis including, but not limited to:
- Cirrhosis
- Hepatocellular carcinoma
- Ascites
- Patients with broken, or injured skin, in the right upper abdominal quadrant.
- Body habitus, or anatomical variation, where the liver capsule is not accessible with ultrasound through the patient's right intercostal imaging window used in conventional ultrasound liver imaging.
- BMI greater than 50 kg/m2
- Patients with subcutaneous fat at measurement location less than or equal to 6mm.
- Patients with a missing liver lobe.
- Patients with peri-hepatic fat in the measurement location.
- Patients with focal liver lesions or anatomical structures in the measurement location, as detected by ultrasound.
Recruiting US locations
ENDRA Life Sciences
Ann Arbor, MI 48105
Site contact: Ava Ohlgren · 734-210-0129 · aohlgren@endrainc.com
Study contacts (from the official record)
- Ziad Rouag · 415-531-4647 · zrouag@endrainc.com
- Ava Ohlgren · 734-315-0090 · aohlgren@endrainc.com
Similar studies in Michigan
All nutrition & metabolism studies in Michigan →- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Detroit, MI + 121 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Chesterfield, MI + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Ann Arbor, MI + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Akero Therapeutics, Inc
- Location
- Novi, MI + 131 other US sites
- Eligibility basics
- Ages 18–80